Seegene Inc
Contact

Not Available for sale in the United States

  • Real-time
    PCR
  • CE-IVD
    marked

Anyplex™ II
MTB/MDR Detection

Simultaneous detection of MTB and 25 mutations associated with MDR-TB using real-time PCR

Anyplex™II MTB/MDR Detection simultaneously detects and identifies Mycobacterium tuberculosis (MTB) and 25 mutations associated with MDR-TB. Based on Seegene’s proprietary DPO™ and TOCE™ technologies, this assay performs on multiplex real-time PCR instruments and provide prompt diagnosis and appropriate treatment guideline for tuberculosis control.

Features

Result

The results indicate the detection of MTB infection in the FAM channel, and the rifampicin-resistance mutation in the HEX channel and the Isoniazid-resistance mutation in the Cal Red 610 channel.

Publication

- Mycobacterium tuberculosis detection and drug susceptibility testing using Anyplex™ Real-time PCR in comparison with standard culture

Note

[1] The WTC is designed to be exhibited the same result pattern with drug-susceptible M. tuberculosis sample. The WTC reaction should be always performed in each testing run, and the drug-resistant result of unknown samples is analyzed on the basis of the result of WTC.

[2] Multi-Drug Resistance